[go: up one dir, main page]

GB0419175D0 - Method of treatment and compositions - Google Patents

Method of treatment and compositions

Info

Publication number
GB0419175D0
GB0419175D0 GB0419175A GB0419175A GB0419175D0 GB 0419175 D0 GB0419175 D0 GB 0419175D0 GB 0419175 A GB0419175 A GB 0419175A GB 0419175 A GB0419175 A GB 0419175A GB 0419175 D0 GB0419175 D0 GB 0419175D0
Authority
GB
United Kingdom
Prior art keywords
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0419175A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cyclacel Ltd
Original Assignee
Cyclacel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyclacel Ltd filed Critical Cyclacel Ltd
Priority to GB0419175A priority Critical patent/GB0419175D0/en
Publication of GB0419175D0 publication Critical patent/GB0419175D0/en
Priority to AU2005276231A priority patent/AU2005276231A1/en
Priority to ES05775408T priority patent/ES2403558T3/en
Priority to CN2005800370898A priority patent/CN101048160B/en
Priority to MX2007002169A priority patent/MX2007002169A/en
Priority to US11/660,249 priority patent/US20080125404A1/en
Priority to EP05775408A priority patent/EP1799230B1/en
Priority to PCT/GB2005/003350 priority patent/WO2006021803A2/en
Priority to CA002576159A priority patent/CA2576159A1/en
Priority to PL05775408T priority patent/PL1799230T3/en
Priority to JP2007528987A priority patent/JP5117189B2/en
Priority to US13/464,362 priority patent/US8809350B2/en
Ceased legal-status Critical Current

Links

GB0419175A 2004-08-27 2004-08-27 Method of treatment and compositions Ceased GB0419175D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GB0419175A GB0419175D0 (en) 2004-08-27 2004-08-27 Method of treatment and compositions
JP2007528987A JP5117189B2 (en) 2004-08-27 2005-08-25 Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases
MX2007002169A MX2007002169A (en) 2004-08-27 2005-08-25 Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases.
ES05775408T ES2403558T3 (en) 2004-08-27 2005-08-25 Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases
CN2005800370898A CN101048160B (en) 2004-08-27 2005-08-25 Purine and pyrimidine CDK inhibitors and their use in the preparation of medicaments for treating autoimmune diseases
AU2005276231A AU2005276231A1 (en) 2004-08-27 2005-08-25 Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases
US11/660,249 US20080125404A1 (en) 2004-08-27 2005-08-25 Purine and Pyrimidine Cdk Inhitbitors and Their use for The Treatment of Autoimmune Diseases
EP05775408A EP1799230B1 (en) 2004-08-27 2005-08-25 Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases
PCT/GB2005/003350 WO2006021803A2 (en) 2004-08-27 2005-08-25 Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases
CA002576159A CA2576159A1 (en) 2004-08-27 2005-08-25 Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases
PL05775408T PL1799230T3 (en) 2004-08-27 2005-08-25 Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases
US13/464,362 US8809350B2 (en) 2004-08-27 2012-05-04 Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0419175A GB0419175D0 (en) 2004-08-27 2004-08-27 Method of treatment and compositions

Publications (1)

Publication Number Publication Date
GB0419175D0 true GB0419175D0 (en) 2004-09-29

Family

ID=33104749

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0419175A Ceased GB0419175D0 (en) 2004-08-27 2004-08-27 Method of treatment and compositions

Country Status (2)

Country Link
CN (1) CN101048160B (en)
GB (1) GB0419175D0 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102140139B (en) * 2010-02-03 2013-01-09 吉林大学 Antitumor human single-chain antibody
CN111039941B (en) * 2018-10-12 2023-03-21 上海医药集团股份有限公司 Nitrogen-containing heterocyclic compound, preparation method and application thereof
CN116024213B (en) * 2022-08-25 2024-03-01 中国人民解放军空军军医大学 Interference fragment for treating psoriasis and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866702A (en) * 1996-08-02 1999-02-02 Cv Therapeutics, Incorporation Purine inhibitors of cyclin dependent kinase 2
US20030229105A1 (en) * 2002-05-21 2003-12-11 Cyclacel Limited Treatment of autoimmune disorders

Also Published As

Publication number Publication date
CN101048160B (en) 2012-07-18
CN101048160A (en) 2007-10-03

Similar Documents

Publication Publication Date Title
LT1791791T (en) Methods and compositions for treatment of water
GB2423928B (en) Methods and compositions for treating pain
GB2414666B (en) Sanitizing composition and method of preparation
EP1737482A4 (en) Compositions and methods for treating diseases
ZA200704677B (en) Compositions and methods for the treatment of autism
IL181896A0 (en) Methods and compositions for the treatment of hyperlipidemia
IL182436A0 (en) Thienopyridinone compounds and methods of treatment
EP1696910A4 (en) Compositions and methods for treatment of fibrosis
IL174627A0 (en) Compositions and methods for treatment of burns
IL178996A0 (en) Thienopyridinone compounds and methods of treatment
IL179931A0 (en) Compositions and methods for treatment of cardiovascular disease
IL187405A0 (en) Methods and compositions for the treatment of pain
EP1786265A4 (en) Novel compositions and methods of treatment
ZA200703087B (en) Methods and compositions for the treatment of hyperlipidemia
GB0324523D0 (en) Compositions and methods of treatment
IL180195A0 (en) Aequorin-containing compositions and methods of using same
ZA200709024B (en) Method of well treatment and construction
EP1824462A4 (en) Composition and method for the treatment of tauopathies
GB0426196D0 (en) Methods of treatment
EP1812797A4 (en) Compositions and methods for the treatment and prevention of hyperproliferative diseases
EP1784193A4 (en) Composition and method for treatment and prevention of atherosclerosis
GB0520930D0 (en) Composition and method of use
GB0419175D0 (en) Method of treatment and compositions
GB0504657D0 (en) Compositions and methods of treatment
GB0419176D0 (en) Method of treatment and compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)